Cover Image

A Novel DNA Aptamer Probe Recognizing Castration Resistant Prostate Cancer in vitro and in vivo Based on Cell-SELEX

Jinman Zhong,1 Duoduo Liu,1 Quanxin Yang,1 Jianke Ding,2 Xin Chen1 1Department of Radiology, The Second Affiliated Hospital, Xi' an Jiaotong University, Xi'an, Shaanxi Province, 710004, People's Republic of China; 2Department of Plastic and Reconstructive Surgery, Xijing Hospital, Fou...

Full description

Saved in:

Bibliographic Details
Main Authors:	Zhong J (Author), Liu D (Author), Yang Q (Author), Ding J (Author), Chen X (Author)
Format:	Book
Published:	Dove Medical Press, 2024-03-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Selection of DNA Aptamers Recognizing EpCAM-Positive Prostate Cancer by Cell-SELEX for in vitro and in vivo MR Imaging
by: Zhong J, et al.
Published: (2021)

In vivo SELEX for Identification of Brain-penetrating Aptamers
by: Congsheng Cheng, et al.
Published: (2013)

Targeting ocular tissues with intravenously administered aptamers selected by in vivo SELEX
by: Sonja Korhonen, et al.
Published: (2024)

Aptamers Against Live Targets: Is In Vivo SELEX Finally Coming to the Edge?
by: Mayte Sola, et al.
Published: (2020)

In Vivo SELEX of an Inhibitory NSCLC-Specific RNA Aptamer from PEGylated RNA Library
by: Hanlu Wang, et al.
Published: (2018)

Rapidly Neutralizable and Highly Anticoagulant Thrombin-Binding DNA Aptamer Discovered by MACE SELEX
by: Koji Wakui, et al.
Published: (2019)

Response and Resistance in Castration-Resistant Prostate Cancer
Published: (2020)

Improving Breast Cancer Treatment Specificity Using Aptamers Obtained by 3D Cell-SELEX
by: Frank H. T. Nelissen, et al.
Published: (2021)

Piperlongumine inhibits migration and proliferation of castration-resistant prostate cancer cells via triggering persistent DNA damage
by: Ding-fang Zhang, et al.
Published: (2021)

Enzalutamide for the treatment of metastatic castration-resistant prostate cancer
by: Rodriguez-Vida A, et al.
Published: (2015)

Targeting mTOR Complex 2 in Castration-Resistant Prostate Cancer with Acquired Docetaxel Resistance
by: Huang Y, et al.
Published: (2022)

New Technologies Provide Quantum Changes in the Scale, Speed, and Success of SELEX Methods and Aptamer Characterization
by: Abdullah Ozer, et al.
Published: (2014)

Base-modified aptamers obtained by cell-internalization SELEX facilitate cellular uptake of an antisense oligonucleotide
by: Keisuke Tanaka, et al.
Published: (2021)

Hybrid-Type SELEX for the Selection of Artificial Nucleic Acid Aptamers Exhibiting Cell Internalization Activity
by: Hiro Uemachi, et al.
Published: (2021)

Taxane resistance in castration-resistant prostate cancer: mechanisms and therapeutic strategies
by: Brandon Bumbaca, et al.
Published: (2018)

Profiling Cancer Cells by Cell-SELEX: Use of Aptamers for Discovery of Actionable Biomarkers and Therapeutic Applications Thereof
by: Sarah Shigdar, et al.
Published: (2021)

Rapid molecular imaging of active thrombi in vivo using aptamer-antidote probes
by: Bethany Powell Gray, et al.
Published: (2023)

Apalutamide: Emerging Therapy for Non-Metastatic Castration-Resistant Prostate Cancer
by: Nora A. Alkhudair
Published: (2019)

Advanced Therapeutic Options for Treatment of Metastatic Castration Resistant Prostatic Adenocarcinoma
by: Faiza Naseer, et al.
Published: (2021)

Integrated high-throughput analysis identifies super enhancers in metastatic castration-resistant prostate cancer
by: Jie Zeng, et al.
Published: (2023)

Cabazitaxel: a novel second-line treatment for metastatic castration-resistant prostate cancer
by: Channing J Paller, et al.
Published: (2011)

Combining independent protein and cellular SELEX with bioinformatic analysis may allow high affinity aptamer hit discovery
by: Coline Ducrot, et al.
Published: (2023)

AptaSUITE: A Full-Featured Bioinformatics Framework for the Comprehensive Analysis of Aptamers from HT-SELEX Experiments
by: Jan Hoinka, et al.
Published: (2018)

Selection of Metastatic Breast Cancer Cell-Specific Aptamers for the Capture of CTCs with a Metastatic Phenotype by Cell-SELEX
by: Wan-Ming Li, et al.
Published: (2018)

Curcumin induces apoptosis and protective autophagy in castration-resistant prostate cancer cells through iron chelation
by: Yang C, et al.
Published: (2017)

Association of Monoamine Oxidase A with Tumor Burden and Castration Resistance in Prostate Cancer
by: Meenakshi Meenu, MBBS, MD, DM, et al.
Published: (2020)

HTA and innovative treatments evaluation: the case of metastatic castration-resistant prostate cancer
by: Bretoni A, et al.
Published: (2019)

LNCaP Atlas: Gene expression associated with <it>in vivo </it>progression to castration-recurrent prostate cancer
by: Marra Marco A, et al.
Published: (2010)

Embelin, a small molecule quinone with a co-clinical power for castrate-resistant prostate cancer
by: Dr. Radhika J Poojari
Published: (2014)

HTA and innovative treatments evaluation: the case of metastatic castration-resistant prostate cancer [Corrigendum]
by: Bretoni A, et al.
Published: (2019)

Targeting castration-resistant prostate cancer with a novel RORγ antagonist elaiophylin
by: Jianwei Zheng, et al.
Published: (2020)

Abiraterone acetate: oral androgen biosynthesis inhibitor for treatment of castration-resistant prostate cancer
by: Rosenberg JE, et al.
Published: (2012)

Cost-Effectiveness of Genomic Test-Directed Olaparib for Metastatic Castration-Resistant Prostate Cancer
by: Dan Su, et al.
Published: (2021)

FOXC2 expression and epithelial-mesenchymal phenotypes are associated with castration resistance, metastasis and survival in prostate cancer
by: Astrid Børretzen, et al.
Published: (2019)

Mechanism of baicalein in treatment of castration-resistant prostate cancer based on network pharmacology and cell experiments
by: Baokai Dou, et al.
Published: (2024)

PROTACs targeting androgen receptor signaling: Potential therapeutic agents for castration-resistant prostate cancer
by: Yulu Zhang, et al.
Published: (2024)

Natural Product-Based Studies for the Management of Castration-Resistant Prostate Cancer: Computational to Clinical Studies
by: Rajeev K. Singla, et al.
Published: (2021)

The Role of Docetaxel in Non-Castrate Resistant Metastatic Prostate Cancer: An Evidence-based Case Report
by: Fakhri Rahman, et al.
Published: (2017)

Metastatic castration-resistant prostate cancer and the challenge of a patient with chronic kidney disease in hemodialysis
by: Joana Simões, et al.
Published: (2018)

Castration-resistant prostate cancer patient presenting with whole genome doubling with CDK-12 mutation
by: Yuto Baba, et al.
Published: (2022)